PPBT
Purple Biotech Ltd.
NASDAQ · Healthcare · Biotechnology · IL
$1.75
−11.62%Jun 11, 2026, 11:00 UTC
Purple Biotech presented new preclinical data for IM1240 at the EACR 2026 conference, highlighting its anti-tumor activity, safety, and pharmacokinetic profile.
Source: